Market Cap (In GBp)
11.72 Million
Revenue (In GBp)
801.96 Thousand
Net Income (In GBp)
-586.24 Thousand
Avg. Volume
747.51 Thousand
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.45-0.9
- PE
- -
- EPS
- -
- Beta Value
- 1.149
- ISIN
- GB00B0923P27
- CUSIP
- G7276D122
- CIK
- -
- Shares
- 2345890000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Ian Ford BA (Hons) ACA, F.C.A.
- Employee Count
- -
- Website
- https://www.provexis.com
- Ipo Date
- 2004-06-28
- Details
- Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
More Stocks
-
IFABFiFabric Corp.
IFABF
-
RPOWERReliance Power Limited
RPOWER
-
ALC
-
ZENITHHEZenith Healthcare Limited
ZENITHHE
-
TCIEXPTCI Express Limited
TCIEXP
-
4193
-
DANHDan Hotels Ltd
DANH
-
AYI